U.S. Bancorp USB AFS and Trading Securities - Unrealized Loss Position (>=12 Months)
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) at other companies
Other financials
Where this comes from
Reported directly by U.S. Bancorp in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger.
The official record: U.S. Bancorp’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about U.S. Bancorp's afs and trading securities - unrealized loss position (>=12 months).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is U.S. Bancorp's AFS and trading securities - unrealized loss position (>=12 months)?
- U.S. Bancorp (USB) reported AFS and trading securities - unrealized loss position (>=12 months) of $42.24B in Q1 2026.
- How has U.S. Bancorp's AFS and trading securities - unrealized loss position (>=12 months) changed year-over-year?
- U.S. Bancorp's AFS and trading securities - unrealized loss position (>=12 months) decreased by 13.8% year-over-year, from $49.02B to $42.24B.
- What is the long-term trend for U.S. Bancorp's AFS and trading securities - unrealized loss position (>=12 months)?
- Over 5 years (2020 to 2025), U.S. Bancorp's AFS and trading securities - unrealized loss position (>=12 months) has grown at a 118.3% compound annual growth rate (CAGR), from $1.03B to $51.02B.
- What does AFS and trading securities - unrealized loss position (>=12 months) mean?
- The total value of investment securities that have been worth less than their cost for over a year.
- How do you interpret AFS and trading securities - unrealized loss position (>=12 months)?
- An increase suggests prolonged market valuation pressure on long-term holdings, potentially signaling future credit impairment risks.
- How does AFS and trading securities - unrealized loss position (>=12 months) compare across companies?
- Commonly reported by large financial institutions under ASC 320 to disclose duration of impairment.